Hypokalemia and rhabdomyolysis
- 1*,
- 1,
- 2,
- 1
- 1Departments of Clinical Pharmacology, Hospital, University of Copenhagen, Denmark.
- 2Internal Medicine, Bispebjerg Hospital, University of Copenhagen, Denmark.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Henrik Horwitz
Departments of Clinical Pharmacology, Hospital, University of Copenhagen, Denmark.
Email: henrik_horwitz@hotmail.com
Copyright: © 2015 The Author(s). This is an open access article.
Published: Jan 1, 2015, Received: Mar 12, 2014, Accepted: Sep 11, 2014
Abstract
The adverse drug event manager of the Capital Region of Denmark received a report of a 65‑year‑old male with type II diabetes and long‑lasting treatment with indapamide. In addition, he had a history of a high consumption of licorice. For 2 weeks, the patient suffered from myalgia, which the general practitioner suspected to be polymyalgia rheumatica and referred him to the hospital. Initial blood samples revealed a reduced potassium concentration of 1.5 mmol/L (reference value: 6.6-4.6 mmol/L) and an elevated creatine kinase of 18,400 IU/L (reference value: 40-280 IU/L). We believe that the patient developed rhabdomyolysis due to severe hypokalemia, possibly induced by a pharmacodynamic interaction between licorice and indapamide.
Keywords
Subject
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026